Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | EOS301984 |
Synonyms | |
Therapy Description |
EOS301984 inhibits ENT1, suppressing adenosine transport and potentially leading to increased T-cell mediated killing of tumor cells (Cancer Res (2024) 84 (6_Supplement): 734). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
EOS301984 | EOS-984|EOS984|EOS 984 | EOS301984 inhibits ENT1, suppressing adenosine transport and potentially leading to increased T-cell mediated killing of tumor cells (Cancer Res (2024) 84 (6_Supplement): 734). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06547957 | Phase I | EOS301984 EOS301984 + unspecified PD-1 antibody | A First-in-Human Study of EOS301984 as Monotherapy or Combination Therapy in Adult Participants With Advanced Solid Tumors | Recruiting | BEL | 0 |